The medical device giant plans to start offering the Micra AV in a limited number of implanting centers in the coming weeks, with a full launch expected in the spring.
FDA initially approved the Micra system in 2016. It’s about the size of a vitamin pill. Implanted inside the heart’s right ventricle via catheter, it does away with the need to run leads to the heart. The system, though, hasn’t been able to provide the therapies associated with dual-chamber pacing systems — until now.